What is the Projected CAGR value of the Carcinoembryonic Antigen (CEA) Market?
Carcinoembryonic Antigen (CEA) Market is expected to grow at a CAGR of 3.9% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
The Key Players are Boster Biological Technology, Quest Diagnostics, F. Hoffman LA Roche, GenWay Biotech Inc., Correlogic Systems, Inc., Abbott Laboratories, RayBiotech, Inc., Omega Diagnostics Group PLC, Merck KGaA and Creative Diagnostics.